rosiglitazone has been researched along with Carotid Arteriopathies, Traumatic in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (75.00) | 29.6817 |
| 2010's | 1 (25.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cho, HJ; Hur, J; Kang, HJ; Kim, HS; Kim, SH; Kim, TY; Kwon, YW; Lee, CS; Park, KW; Park, YB; Yang, HM | 1 |
| Balazs, L; Cheng, Y; Farrar, P; Guo, H; Makarova, N; Shuyu, E; Tigyi, G; Tsukahara, R; Zhang, C | 1 |
| Fang, CQ; Gao, CY; Gao, D; Li, JC; Wang, JZ; Wang, YJ; Xiang, J; Yao, GE; Zhang, LL | 1 |
| Barringhaus, KG; Chen, M; Czarnik, AC; Hesselbacher, S; Ley, K; Nadler, J; Phillips, JW; Sanders, JM; Sarembock, IJ; Yang, Z | 1 |
4 other study(ies) available for rosiglitazone and Carotid Arteriopathies, Traumatic
| Article | Year |
|---|---|
New mechanism of rosiglitazone to reduce neointimal hyperplasia: activation of glycogen synthase kinase-3beta followed by inhibition of MMP-9.
Topics: Animals; Apoptosis; Carotid Artery Injuries; Cell Movement; Cell Proliferation; Cell Survival; Cells, Cultured; Disease Models, Animal; Dose-Response Relationship, Drug; Enzyme Activation; Enzyme Activators; Extracellular Signal-Regulated MAP Kinases; Gene Transfer Techniques; Glycogen Synthase Kinase 3; Glycogen Synthase Kinase 3 beta; Hyperplasia; Matrix Metalloproteinase 9; Matrix Metalloproteinase Inhibitors; Mice; Mice, Knockout; Muscle, Smooth, Vascular; Mutation; Myocytes, Smooth Muscle; NF-kappa B; Protease Inhibitors; Rats; Rats, Sprague-Dawley; Rosiglitazone; Signal Transduction; Thiazolidinediones; Tunica Intima | 2009 |
Lysophosphatidic acid-induced arterial wall remodeling: requirement of PPARgamma but not LPA1 or LPA2 GPCR.
Topics: Animals; Carotid Artery Injuries; Carotid Artery, Common; Gene Knockdown Techniques; Glycerophosphates; Hypoglycemic Agents; Lysophospholipids; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; PPAR gamma; Rats; Rats, Sprague-Dawley; Receptors, G-Protein-Coupled; Rosiglitazone; Thiazolidinediones | 2009 |
PPARĪ³ attenuates intimal hyperplasia by inhibiting TLR4-mediated inflammation in vascular smooth muscle cells.
Topics: Animals; Carotid Artery Injuries; Cell Movement; Cell Proliferation; Cells, Cultured; Disaccharides; Disease Models, Animal; Hyperplasia; Inflammation; Lipopolysaccharides; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Muscle, Smooth, Vascular; Myocytes, Smooth Muscle; Platelet-Derived Growth Factor; PPAR gamma; RNA Interference; Rosiglitazone; Sugar Phosphates; Thiazolidinediones; Toll-Like Receptor 4; Transfection; Tunica Intima | 2011 |
Rosiglitazone reduces the accelerated neointima formation after arterial injury in a mouse injury model of type 2 diabetes.
Topics: Animals; Blood Glucose; Carotid Arteries; Carotid Artery Injuries; Cells, Cultured; Diabetes Mellitus, Type 2; Diet; Disease Models, Animal; Female; Homozygote; Hyperglycemia; Hyperinsulinism; Hypoglycemic Agents; Insulin; Insulin Resistance; Islets of Langerhans; Lipids; Macrophages; Mice; Mice, Inbred C57BL; Mice, Knockout; Muscle, Smooth, Vascular; Rosiglitazone; Thiazoles; Thiazolidinediones; Tunica Intima | 2003 |